AGA living guideline recommends patients start advanced therapies early in their disease course rather than gradual step-up treatment approach. “Since the first biologic treatment for ulcerative ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

For people with UC, ‘feeling better’ is just the start. Learn why tissue-level (histological) healing is becoming the new gold standard for UC remission and cancer prevention.

Medications are the foundation of treatment for moderate to severe ulcerative colitis (UC), with advanced therapies like JAK inhibitors, immunosuppressants, and biologics often playing a key role in ...

Imagine you and your gastroenterologist have discussed a new ulcerative colitis (UC) treatment plan that promises to reduce your symptoms and the stress that comes with them. Then, when you go to ...

Aminosalicylate (5-ASA) therapy is often the first treatment option for patients presenting with mild to moderate ulcerative colitis (UC). Symptom improvements can be observed within 2 to 4 weeks ...

Please provide your email address to receive an email when new articles are posted on . A greater proportion of patients in the PRA023 group achieved clinical remission at 12 weeks vs. placebo (26.5% ...

The vast majority of insurance companies require patients with Crohn's disease and ulcerative colitis to fail conventional treatment with steroids and immunomodulators before starting biologic therapy ...

Nearly 70% of adolescents and young adults stop taking oral 5-aminosalicylic acid (5-ASA) maintenance therapy within 12 months of ulcerative colitis (UC) diagnosis, new research from the United ...

Colitis Symptoms Ulcerative Colitis Symptoms How They Differ Treatment Options Colitis and ulcerative colitis (UC) can look very similar because they share symptoms like abdominal pain, diarrhea, and ...

Bethesda, MD (Nov. 15, 2024) — The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe ulcerative colitis, ...